Form 8-K Axsome Therapeutics, For: Jul 25 StreetInsider.com
Washington, D.C. 20549. FORM 8-K. CURRENT REPORT. Pursuant to Section 13 or 15(d). of the Securities Exchange Act of 1934. July 25, 2019. Date of report …
Form 8-K Axsome Therapeutics, For: Jul 25 StreetInsider.com
Washington, D.C. 20549. FORM 8-K. CURRENT REPORT. Pursuant to Section 13 or 15(d). of the Securities Exchange Act of 1934. July 25, 2019. Date of report …